Meet the Alba team at the AABB Annual Meeting to learn how our high-quality blood bank reagents can drive value in your lab!
Sign up for a booth meeting with your Account Executive today.
Join us at AABB 2024!
Trending Topics
Our passion for the work we do is matched only by our commitment to consistently provide the best customer experience possible.
-
AliveDx Suisse S.A. and Disera Tibbi Malzeme Lojistik. san. Tic. A.S sign Distribution Agreement in Türkiye
AliveDx Suisse S.A. and Disera Tibbi Malzeme Lojistik. san. Tic. A.S have signed a distribution agreement, which will enable Disera to distribute the MosaiQ® and LumiQ™ solutions in Türkiye. The distribution agreement takes effect immediately. This strategic partnership with an
-
AliveDx Suisse S.A. and Vital Care SPA sign distribution agreement in Algeria
AliveDx Suisse S.A. and Vital Care Prod SPA have signed a distribution agreement, which will enable Vital Care to distribute the MosaiQ® and LumiQ™ solutions in Algeria. The distribution agreement takes effect immediately. This partnership underscores AliveDx’s dedication to broadening
-
Alba Bioscience Limited and Medline Industries, LP sign distribution agreement for Alba reagents in the USA
Alba Bioscience Limited and Medline Industries, LP have signed a distribution agreement, which will enable Medline to distribute Alba’s range of reagents in the USA. The distribution agreement takes effect immediately. Alba develops and manufactures high-quality blood bank reagents for
-
Join our webinar with Dr. Gerber Gomez: Multiplex Autoantibody Testing in the Serological Evaluation of Autoimmune Disease
Are you facing challenges in achieving accurate, timely diagnoses for patients with suspected autoimmune conditions? Join us for an exclusive webinar where Dr. Gerber Gomez, Scientific & Medical Officer at AliveDx, will share: Date: 13 March 2025 Time: 14h00-15h00 CET
-
MosaiQ AiPlex® Celiac Disease (CD) solution obtains Medical Device Authority (MDA) registration in Malaysia
We are excited to announce that our MosaiQ AiPlex® Celiac Disease (CD) solution has obtained Medical Device Authority (MDA) registration in Malaysia! The registration confirms the safety, quality, and effectiveness of our system. With this approval, AliveDx is now authorized
-
Alba Bioscience completes UK NHS Evergreen Sustainable Supplier Assessment and achieves Level 2
Alba Bioscience is pleased to have completed the UK National Health Service (NHS) Evergreen Sustainable Supplier Assessment. The Assessment is a self-assessment and reporting tool and resulted in Alba Bioscience receiving a Level 2: Comprehensive net zero targets and reporting
